Evolution Wealth Advisors LLC Boosts Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Evolution Wealth Advisors LLC boosted its position in iShares Biotechnology ETF (NASDAQ:IBB) by 5.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,688 shares of the financial services provider’s stock after buying an additional 1,156 shares during the period. Evolution Wealth Advisors LLC’s holdings in iShares Biotechnology ETF were worth $3,132,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Security National Bank of SO Dak boosted its position in shares of iShares Biotechnology ETF by 0.7% during the 2nd quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock worth $1,436,000 after purchasing an additional 75 shares in the last quarter. SPC Financial Inc. boosted its position in shares of iShares Biotechnology ETF by 2.4% during the 3rd quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after purchasing an additional 75 shares in the last quarter. Werba Rubin Papier Wealth Management boosted its position in shares of iShares Biotechnology ETF by 2.7% during the 3rd quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock worth $425,000 after purchasing an additional 76 shares in the last quarter. Capital Investment Advisors LLC boosted its position in shares of iShares Biotechnology ETF by 1.0% during the 4th quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock worth $1,381,000 after purchasing an additional 99 shares in the last quarter. Finally, Prairie Wealth Advisors Inc. boosted its position in shares of iShares Biotechnology ETF by 6.0% during the 2nd quarter. Prairie Wealth Advisors Inc. now owns 1,765 shares of the financial services provider’s stock worth $242,000 after purchasing an additional 100 shares in the last quarter. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ IBB opened at $136.29 on Thursday. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57. The company’s fifty day moving average is $136.00 and its two-hundred day moving average is $141.81.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.